-
Manufacturing
API & Intermediates Manufacturing
Commercial Plants
Anhui Ma’anshan c-GMP Manufacturing Site
-
Total Area：87,860 m2 -
Reactors numbers：110+
-
Total volume: ~310,000L
ADC & HPAPI GMP Plants
Ma’anshan, Anhui Province — ADC & HPAPI Manufacturing
-
1500m2 HPAPI GMP kg scale plant in production since 2021
-
2,900m2 under construction
-
Total volume : 3,000L
-
Tofflon separator (OEL <1μg/m3 ) covering in the full spectrum of HPAPI of pharma
-
SOP controlled exposure: Maximum HPAPI safety is achieved by negative pressure separators for weighing, process development, pre-lyophilization handling. End-to-end production management in controlled working area
-
Scheduled monitoring: Air dust detection and alarm system, continuous staff training (SOP for PPE, emergency response, etc)
Drug Product
Jiangsu GMP Manufacturing
-
5 independent Class D manufacturing areas
-
Oral solid dosages: 4 workshops; annual manufacturing capacity: ~1 billion units
-
Semi solid topical dosages: 2 workshop; annual manufacturing capacity: ~ 40 million tubes
-
GMP warehouses of various storage conditions including cold storage
-
Formulation development and manufacturing capabilities include tablets, hard capsules, granules, powders, creams, ointment and gels, including anti-tumor drugs (OEB3/4)
Learn About Our Products
